BACKGROUND AND OBJECTIVES: A pluripotent progenitor cell was demonstrated to be involved in myelodysplastic syndromes (MDS) with normal karyotype or with numerical chromosome aberrations, but the pattern of lineage involvement by the 5q31 deletion in the 5q- syndrome is unknown. We performed this study in order to define the distribution pattern of the 5q- anomaly better in the non-lymphoid cell compartment DESIGN AND METHODS: Bone marrow (BM) smears from 8 patients with the 5q- syndrome were studied by a modification of the fluorescent in situ hybridization (FISH) technique that allowed direct visualization of cell morphology. A commercial LSI EGR1 probe (Vysis Inc.) for the 5q31 band was used simultaneously in dual-color experiments with ...
Molecular cytogenetic techniques enabled us to clarify numerical and structural alterations previous...
Bone marrow and blood from patients with acute myeloid leukemia and myelodysplastic syndrome were st...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological malignancies. A s...
Abstract: Background and Objectives. A pluripotent progenitor cell was demonstrated to be involved i...
The 5q- syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory...
Fluorescence in situ hybridization (FISH) with a locus-specific dual DNA probe (LSI EGR-1SO/D5S23SG)...
We characterized the cytogenetic changes and prognostic characteristics of 133 Korean patients with ...
We characterized the cytogenetic changes and prognostic characteristics of 133 Korean patients with ...
The 5q- syndrome is a distinct hematological disorder with typical laboratory, morphological, cytoge...
Myelodysplastic syndrome (MDS) can easily transform into acute myeloid leukemia (AML), a process whi...
At diagnosis, approximately half of myelodysplastic (MDS) patients presents a normal karyotype by co...
Deletions spanning chromosome 5q31.2 are among the most common recurring cytogenetic abnormalities d...
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell malignan...
Partial deletion of the long arm of chromosome 5, del(5q), is the cytogenetic hallmark of the 5q-syn...
In 1974 Herman van den Berghe et al. [1][1] reported a distinct hematologic disorder associated with...
Molecular cytogenetic techniques enabled us to clarify numerical and structural alterations previous...
Bone marrow and blood from patients with acute myeloid leukemia and myelodysplastic syndrome were st...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological malignancies. A s...
Abstract: Background and Objectives. A pluripotent progenitor cell was demonstrated to be involved i...
The 5q- syndrome is a distinct subtype of myelodysplastic syndrome (MDS) characterized by refractory...
Fluorescence in situ hybridization (FISH) with a locus-specific dual DNA probe (LSI EGR-1SO/D5S23SG)...
We characterized the cytogenetic changes and prognostic characteristics of 133 Korean patients with ...
We characterized the cytogenetic changes and prognostic characteristics of 133 Korean patients with ...
The 5q- syndrome is a distinct hematological disorder with typical laboratory, morphological, cytoge...
Myelodysplastic syndrome (MDS) can easily transform into acute myeloid leukemia (AML), a process whi...
At diagnosis, approximately half of myelodysplastic (MDS) patients presents a normal karyotype by co...
Deletions spanning chromosome 5q31.2 are among the most common recurring cytogenetic abnormalities d...
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell malignan...
Partial deletion of the long arm of chromosome 5, del(5q), is the cytogenetic hallmark of the 5q-syn...
In 1974 Herman van den Berghe et al. [1][1] reported a distinct hematologic disorder associated with...
Molecular cytogenetic techniques enabled us to clarify numerical and structural alterations previous...
Bone marrow and blood from patients with acute myeloid leukemia and myelodysplastic syndrome were st...
Myelodysplastic syndromes (MDS) represent a heterogeneous group of haematological malignancies. A s...